References
- Fisher B, Carbone P, Economou S, et al. L-Phenylalanine mustard (L-PAM) In the management of primary breast cancer: a report of early findings. N Engl J Med 1975: 292(3): 117–22
- Bonadonna G, Brusamolino E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976: 294(8): 405–10
- Fisher B. Breast cancer: studies of the National Surgical Adjuvant Primary Breast Cancer Project (NSABP). In: Jones SE, Salmon SE, eds. Adjuvant therapy of cancer II. New York: Grune & Stratton, 1979
- Rockette HE, Redmond CK, Fisher B, et al. Impact of randomized clinical trials on therapy of primary breast cancer: the NSABP overview. Controlled Clin Trials 1982: 3(3): 209–25
- Bonadonna G, Rossi A, Valagussa P, et al. Adjuvant chemotherapy with CMF in breast cancer with positive axillary nodes. In: Salmon SE, Jones SE, eds. Adjuvant therapy of cancer: first international conference, Tucson. Ariz, 2–5 Mar 1977. New York: Elsevier-North Holland, 1977: 83–95
- Bonadonna G, Valagussa P, Rossi A, et al. CMF adjuvant chemotherapy in operable breast cancer. In: Jones, Salmon, eds,3 pp 114–9
- Bonadonna G, Valagussa P, Rossi A, et al. Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan experience. In: Salmon SE, Jones SE, eds. Adjuvant therapy of cancer III. New York: Grune & Stratton, 1981: 435–45
- Rossi A, Bonadonna G, Valagussa P, et al. CMF adjuvant program for breast cancer: 5-year results. (Abstr) Proc Amer Assoc Can Res-Amer Soc Clin Oncol 1980: 21: 404
- Senn HJ, Jungi WF, Amgwerd. Chemo (immuno) therapy with LMF + BOG In node negative and node positive breast cancer. In: Salmon, Jones, eds,7 pp 385–95
- Tormey DC, Kalish L, Cummings FJ, et al. Premenopausal breast cancer adjuvant chemotherapy: the Eastern Cooperative Oncology Group Trial. (Abstr) Proc Amer Soc Clin Oncol 1983: 2: 102
- Glucksberg H, Rivkin SE, Rasmussen S, et al. Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study. Cancer 1982: 50(3): 423–34
- Ahmann DL, Payne WS, Scanlon PW, et al. Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancer. Lancet 1978: 1(8070): 893–6
- Caprini JA, Oviedo MA, Cunningham MP, et al. Adjuvant chemotherapy for stage II and III breast carcinoma. JAMA 1980: 244(3): 243–6
- Cooper MR, Rhyne AL, Muss HB, et al. A randomized comparative trial of chemotherapy and irradiation therapy for stage II breast cancer. Cancer 1981: 47(12): 2833–9
- Bonadonna G, Valagussa P. Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 1981: 304(1): 10–5
- Meaken JW, Allt WE, Beale FA. Ovarian irradiation and prednisone following surgery for carcinoma of the breast. In: Salmon, Jones, eds,5 pp 95–100
- Fisher B, Redmond CK, Brown A, et al. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. J Clin Oncol 1983: 1(4): 227–41